Our latest news for ‘NAFLD’

We are proud to be leading the way in providing more patient-centric solutions for people with liver disease that helps them and their physician make informed decisions about their care.

Read our latest news to find out more about how we are helping to improve the understanding of liver disease.

Video: An FDA-Cleared Non-Invasive Test for Liver Disease Posted: April 1, 2020

LiverMultiScan liver health liver disease high risk group immunosuppressed liver transplant liver cancer liver patients Fatty Liver Disease NAFLD MRI Liver Disease

[Press Release] Large population imaging study reveals utility of LiverMultiScan’s corrected T1 measure as potential biomarker for liver health in metabolic diseases Posted: July 27, 2018

Liver Disease Biomarker liverhealth NAFLD NASH ClinicalTrials

Multiparametric liver MRI could refine the way we currently approach testing of therapeutic candidates in preclinical models Posted: July 3, 2018

Liver Disease NAFLD NASH LiverMultiScan

BBC presents LiverMultiScan on the ‘The Big Crash Diet’ Posted: May 30, 2018

LiverMultiScan NAFLD NASH Liver Disease BBC